機構典藏系統109年2月發表論文 NEW!

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO.(IF 2018:14.196)

Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer.(IF 2018:12.804)

The preparation of cell-containing microbubble scaffolds to mimic alveoli structure as 3D drug screening system for lung cancer.(IF 2018:7.236)

Oligo-fucoidan prevents M2 macrophage differentiation and HCT116 tumor progression.(IF 2018:6.162)

Unique sulfur-aromatic interactions contribute to the binding of potent imidazothiazole indoleamine 2,3-Dioxygenase inhibitors.(IF 2018:6.054)